Nektar (NKTR) Q2 2026 Earnings Call Transcript
Phase 3 trials for rezpegaldesleukin advance in atopic dermatitis and alopecia areata.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Finance & Markets
Tenon Medical (TNON) Q2 2026 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
INDEC data shows economy improved in June after uneven first half of year
Mining and agriculture drive growth but economists warn the recovery remains uneven and should be viewed with caution. Leer más
StoneCo (STNE) Q2 2026 Earnings Call Transcript
Credit portfolio doubled as management navigates higher rates and defaults.
Why the US economy is ringing alarm bells
The US hit a debt milestone this week, but just how worried should we be about the world's largest economy?
Australian Dollar weakens as US yields rebound, PMIs fail to impress
The Australian Dollar retreated against the Greenback on Thursday as US bond yields resumed their advance, despite the US Treasury's efforts to cap elevated yields following its announcement of a…
AudioEye (AEYE) Q2 2026 Earnings Call Transcript
Revenue hit $10.7 million with 42 straight quarters of growth; EBITDA guidance was raised.